OVERVIEW

Novel Mechanisms in the Management of Acute Myeloid Leukemia: A 2018 Update for Pharmacists is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians.

Published: August 24, 2018
Expires: August 24, 2019

Credits: 1.0 hour (0.1 ceu)

Target Audience:
This accredited activity has been designed for pharmacists.

Goal:
To inform oncology, managed care and specialty pharmacists, as well as other pharmacists who interact with Acute Myeloid Leukemia (AML) patients, on (1) novel and emerging therapeutic options in AML and their mechanisms of action (2) the efficacy and safety of current and emerging treatment considerations for AML; (3) approaches to recognize AML patients who are likely to benefit from newly approved therapeutic options or novel targeted agents; and (4) pharmacist driven strategies to manage patients' adherence and unique adverse events when utilizing oral chemotherapy agents thus leading to improved outcomes.

Educational Objectives:
Upon completion of this program, participants should be better able to:
• Review the epidemiology, pathophysiology and traditional approaches for the management of acute myeloid leukemia (AML).
• Discuss the indications, efficacy, safety and mechanism of action of medications recently approved for the management of patients with AML.
• Describe the pivotal clinical trial data considered by the FDA during review in order to recognize AML patients who are likely to benefit from novel therapies.
• Identify the signs and symptoms of adverse effects of these agents and choose appropriate management strategies.

Additional details will be posted as soon as they are available.